John Lilleyman

Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations

Lynne Lennard, Jon A. Van Loon, John Lilleyman et al. · Clinical Pharmacology & Therapeutics · 1987 · 348 citations

Medicine, Hematology, Pharmacology +13

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia

Christine J. Harrison, Anthony V. Moorman, Zoë J. Broadfield et al. · British Journal of Haematology · 2004 · 234 citations

Life Sciences, Genetics, Hematology +17

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial

Ajay Vora, Chris Mitchell, Lynne Lennard et al. · The Lancet · 2006 · 187 citations

Medicine, Hematology, Oncology +16

Reducing adverse events in blood transfusion

D. Stainsby, Joan Russell, Hannah Cohen et al. · British Journal of Haematology · 2005 · 111 citations · Full text

Medicine, Hematology, Patient Safety +16

Individualizing Therapy with 6-Mercaptopurine and 6-Thioguanine Related to the Thiopurine Methyltransferase Genetic Polymorphism

Lynne Lennard, John Lilleyman · Therapeutic Drug Monitoring · 1996 · 89 citations

Medicine, Pharmacology, Pharmacotherapy +15